Acurx Pharmaceuticals, Inc. (ACXP) Operating income 2024–2025
Acurx Pharmaceuticals, Inc. (ACXP) annual operating income history from SEC filings — each fiscal year as reported.
-$8.1MFY2025 · since FY2024: -$14.1M → -$8.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$8.1M | +42.7% |
| FY2024 | -$14.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ACXP financial trends
ACXP RevenueACXP Net incomeACXP Net marginACXP Gross profitACXP Gross marginACXP Operating marginACXP Operating cash flowACXP Free cash flowACXP Capital expendituresACXP Return on equityACXP Stock buybacksACXP Dividends paidACXP Total assetsACXP Total liabilitiesACXP Shareholders’ equityACXP overview →